Showing results (881-890 of 1,198) with videos related to

Sort By:
Pageof 120
Biosensors|April 13, 2018
Raman Spectroscopic and Microscopic Analysis for Monitoring Renal Osteodystrophy SignaturesJohn D Ciubuc, Marian Manciu, Avudaiappan Maran, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 17, 1998
Combined fluorine-18-FDG and carbon-11-methionine PET for diagnosis of tumors in lung and mediastinumO S Nettelbladt, A E Sundin, S O Valind, et al.
Journal of Neuroendocrinology|November 30, 2025
11C-Hydroxyephedrine PET/CT for preoperative surgical planning in large pheochromocytoma and paragangliomaAchyut Ram Vyakaranam, Olov Norlén, Alina Akural, et al.
Journal of Neuroendocrinology|May 5, 2025
The impact of re-characterizing metastatic pancreatic neuroendocrine tumors: A prospective studyKazhan Mollazadegan, Johan Botling, Britt Skogseid, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 4, 2017
Risk Factors for Severe Acute Graft-versus-Host Disease in Donor Graft CompositionArwen Stikvoort, Ahmed Gaballa, Martin Solders, et al.
Haematologica|September 24, 2013
Risk factors for Epstein-Barr virus-related post-transplant lymphoproliferative disease after allogeneic hematopoietic stem cell transplantationMichael Uhlin, Helena Wikell, Mikael Sundin, et al.
Scandinavian Journal of Urology and Nephrology|January 1, 1986
Cardiovascular complications of estrogen therapy for nondisseminated prostatic carcinoma. A preliminary report from a randomized multicenter studyR Lundgren, T Sundin, S Colleen, et al.
Advances in Medical Education and Practice|May 17, 2021
An Interprofessional Senior Medical Student Preparation Course: Improvement in Knowledge and Self-Confidence Before Entering Surgical TrainingBrent Bauman, Peter Kernahan, Anthony Weinhaus, et al.
Journal of Neuroendocrinology|March 13, 2024
Hypoalbuminemia, but not derived neutrophil to lymphocyte ratio (dNLR), predicts overall survival in neuroendocrine tumours undergoing peptide receptor radionuclide therapy: A retrospective, cohort study of 557 patientsDimitrios Papantoniou, Katarzyna Fröss-Baron, Ulrike Garske-Román, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 10, 2023
Changes in tumor-to-blood ratio as a prognostic marker for progression-free survival and overall survival in neuroendocrine tumor patients undergoing PRRTManuel Weber, Olof Pettersson, Robert Seifert, et al.
Pageof 120